Tauopathies

Top drugs studied for this disease

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

FDA approval · 2024-02-05
FDA Approved: TAUVID — Supplemental Application (Eli Lilly and Company)
FDA approved a supplemental application for Tauvid (flortaucipir F-18) enabling its use for PET imaging of tau neurofibrillary tangles in ad…